163 related articles for article (PubMed ID: 34910395)
1. Comparison of treatment outcomes of surgery and radiotherapy, including concurrent chemoradiotherapy for stage Ib2-IIb cervical adenocarcinoma patients: a retrospective study.
Kondo E; Yoshida K; Tabata T; Kobayashi Y; Yamagami W; Ebina Y; Kaneuchi M; Nagase S; Machida H; Mikami M
J Gynecol Oncol; 2022 Mar; 33(2):e14. PubMed ID: 34910395
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant Chemotherapy Followed by Radical Surgery versus Radiotherapy (with or without Chemotherapy) in Patients with Stage IB2, IIA, or IIB Cervical Cancer: A Systematic Review and Meta-Analysis.
Ye Q; Yang Y; Tang X; Li J; Li X; Zhang Y
Dis Markers; 2020; 2020():7415056. PubMed ID: 32802215
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the survival outcome of neoadjuvant therapy followed by radical surgery with that of concomitant chemoradiotherapy in patients with stage IB2-IIIB cervical adenocarcinoma.
Tian T; Gao X; Ju Y; Ding X; Ai Y
Arch Gynecol Obstet; 2021 Mar; 303(3):793-801. PubMed ID: 33009996
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy plus surgery versus concurrent chemoradiotherapy in stage IB2-IIB cervical cancer: A systematic review and meta-analysis.
Zou W; Han Y; Zhang Y; Hu C; Feng Y; Zhang H; Wang J
PLoS One; 2019; 14(11):e0225264. PubMed ID: 31725793
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant Platinum-based Chemotherapy Followed by Radical Hysterectomy for Stage Ib2-IIb Adenocarcinoma of the Uterine Cervix - An Italian Multicenter Retrospective Study.
Gadducci A; Landoni F; Cosio S; Zizioli V; Zola P; Ferrero AM; Lapresa MT; Maggino T; Sartori E
Anticancer Res; 2018 Jun; 38(6):3627-3634. PubMed ID: 29848719
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of postoperative simple chemotherapy and concurrent chemoradiotherapy in FIGO stage IB2-IIB cervical cancer].
Ma K; Yang YH; Yang X; Feng ZY; Liu TY; Wen HW; Liao QP
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Dec; 45(6):910-5. PubMed ID: 24343073
[TBL] [Abstract][Full Text] [Related]
7. Definite chemoradiotherapy is a competent treatment option in FIGO stage IB2 cervical cancer compared with radical surgery +/- neoadjuvant chemotherapy.
Hsieh HY; Huang JW; Lu CH; Lin JC; Wang L
J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):99-108. PubMed ID: 29429800
[TBL] [Abstract][Full Text] [Related]
8. Perioperative treatments for stage IB-IIB uterine cervical cancer.
Shimada M; Tokunaga H; Kobayashi H; Ishikawa M; Yaegashi N
Jpn J Clin Oncol; 2020 Feb; 50(2):99-103. PubMed ID: 31868879
[TBL] [Abstract][Full Text] [Related]
9. Pathological Risk Factors and Outcomes in Women With Stage IB2 Cervical Cancer Treated With Primary Radical Surgery Versus Chemoradiotherapy.
Bradbury M; Founta C; Taylor W; Kucukmetin A; Naik R; Ang C
Int J Gynecol Cancer; 2015 Oct; 25(8):1476-83. PubMed ID: 26244756
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemotherapy followed by radical surgery versus concurrent chemoradiotherapy in patients with FIGO stage IIB cervical cancer: the CSEM 006 study.
Tu H; Huang H; Ouyang Y; Liu Q; Xian B; Song K; Chen G; Shen Y; Liu J
Int J Gynecol Cancer; 2021 Jan; 31(1):129-133. PubMed ID: 32522771
[TBL] [Abstract][Full Text] [Related]
11. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.
Yin M; Zhao F; Lou G; Zhang H; Sun M; Li C; Hou Y; Li X; Meng F; Chen X
Int J Gynecol Cancer; 2011 Jan; 21(1):92-9. PubMed ID: 21330834
[TBL] [Abstract][Full Text] [Related]
12. Operable Stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy.
Atlan D; Touboul E; Deniaud-Alexandre E; Lefranc JP; Antoine JM; Jannet D; Lhuillier P; Uzan M; Huart J; Genestie C; Antoine M; Jamali M; Ganansia V; Milliez J; Uzan S; Blondon J
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):780-93. PubMed ID: 12377330
[TBL] [Abstract][Full Text] [Related]
13. Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study.
Landoni F; Sartori E; Maggino T; Zola P; Zanagnolo V; Cosio S; Ferrari F; Piovano E; Gadducci A
Gynecol Oncol; 2014 Mar; 132(3):611-7. PubMed ID: 24342439
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy after surgery can improve clinical outcomes for patients with IB2-IIB cervical cancer with neoadjuvant chemotherapy followed by radical surgery.
Sun H; Huang K; Tang F; Li X; Wang X; Long S; Zhou S; Suolangquzhen ; Zhang J; Ning R; Li S; Wang S; Ma D
Sci Rep; 2018 Apr; 8(1):6443. PubMed ID: 29691415
[TBL] [Abstract][Full Text] [Related]
15. Long-term treatment outcomes/toxicities of definite chemoradiotherapy (intensity-modulated radiation therapy) for early-stage "bulky" cervical cancer and survival impact of histological subtype.
Hsieh HY; Lu CH; Wang L
J Formos Med Assoc; 2023 Mar; 122(3):221-229. PubMed ID: 36379808
[TBL] [Abstract][Full Text] [Related]
16. Management of Stage IIB Cervical Cancer: an Overview of the Current Evidence.
Matsuzaki S; Klar M; Mikami M; Shimada M; Grubbs BH; Fujiwara K; Roman LD; Matsuo K
Curr Oncol Rep; 2020 Feb; 22(3):28. PubMed ID: 32052204
[TBL] [Abstract][Full Text] [Related]
17. Randomized Phase III Study Comparing Neoadjuvant Chemotherapy Followed by Surgery Versus Chemoradiation in Stage IB2-IIB Cervical Cancer: EORTC-55994.
Kenter GG; Greggi S; Vergote I; Katsaros D; Kobierski J; van Doorn H; Landoni F; van der Velden J; Reed N; Coens C; van Luijk I; Colombo N; Steen-Banasik EV; Ottevanger N; Casado A;
J Clin Oncol; 2023 Nov; 41(32):5035-5043. PubMed ID: 37656948
[TBL] [Abstract][Full Text] [Related]
18. A retrospective review of patients with stage IB2 cervical cancer treated with radical radiation versus radical surgery as a primary modality.
Alleyne-Mike K; van Wijk L; Hunter A
Int J Gynecol Cancer; 2013 Sep; 23(7):1287-94. PubMed ID: 23863456
[TBL] [Abstract][Full Text] [Related]
19. Outcome of stage IB2-IIB patients with bulky uterine cervical cancer who underwent neoadjuvant chemotherapy followed by radical hysterectomy.
Uegaki K; Shimada M; Sato S; Deura I; Naniwa J; Sato S; Oishi T; Itamochi H; Harada T; Kigawa J
Int J Clin Oncol; 2014 Apr; 19(2):348-53. PubMed ID: 23592280
[TBL] [Abstract][Full Text] [Related]
20. A prospective randomized controlled study on multiple neoadjuvant treatments for patients with stage IB2 to IIA cervical cancer.
Wen H; Wu X; Li Z; Wang H; Zang R; Sun M; Huang X; Zhang Z; Cai S
Int J Gynecol Cancer; 2012 Feb; 22(2):296-302. PubMed ID: 22274319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]